Imugene Market Cap

Imugene has a market cap or net worth of 283.38 million as of February 21, 2025. Its market cap has decreased by -64.80% in one year.

Market Cap

283.38M

Enterprise Value

191.56M

Revenue

4.97M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.04

Market Cap Chart

Since September 17, 2002, Imugene's market cap has increased from 7.38M to 283.38M, an increase of 3,740.52%. That is a compound annual growth rate of 17.65%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	283.38M	2.98%
Dec 31, 2024	275.18M	-65.11%
Dec 29, 2023	788.60M	-15.31%
Dec 30, 2022	931.15M	-59.62%
Dec 31, 2021	2.31B	386.45%
Dec 31, 2020	474.09M	234.74%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	125.25B
Pro Medicus	29.87B
Cochlear	17.59B
Sonic Healthcare	13.15B
Telix Pharmaceuticals	10.15B
Ramsay Health Care	7.87B
Ansell	5.19B
Mesoblast	3.38B

Market Cap Rankings